SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040357
Filing Date
2019-11-05
Accepted
2019-11-05 16:04:10
Documents
49
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbay-10q_20190930.htm   iXBRL 10-Q 2572629
2 EX-31.1 cbay-ex311_8.htm EX-31.1 15435
3 EX-31.2 cbay-ex312_9.htm EX-31.2 15338
4 EX-32.1 cbay-ex321_7.htm EX-32.1 8014
  Complete submission text file 0001564590-19-040357.txt   8231814

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20190930.xsd EX-101.SCH 34720
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20190930_cal.xml EX-101.CAL 47087
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20190930_def.xml EX-101.DEF 80497
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20190930_lab.xml EX-101.LAB 289011
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20190930_pre.xml EX-101.PRE 205338
27 EXTRACTED XBRL INSTANCE DOCUMENT cbay-10q_20190930_htm.xml XML 1922025
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 191193244
SIC: 2834 Pharmaceutical Preparations